Chapter 24. Myoclonus

  1. Mark Hallett5 and
  2. Werner Poewe6
  1. Shu-Ching Hu1,3,
  2. Steven J. Frucht2,3 and
  3. Hiroshi Shibasaki4

Published Online: 29 OCT 2008

DOI: 10.1002/9780470713990.ch24

Therapeutics of Parkinson's Disease and Other Movement Disorders

Therapeutics of Parkinson's Disease and Other Movement Disorders

How to Cite

Hu, S.-C., Frucht, S. J. and Shibasaki, H. (2008) Myoclonus, in Therapeutics of Parkinson's Disease and Other Movement Disorders (eds M. Hallett and W. Poewe), John Wiley & Sons, Ltd, Chichester, UK. doi: 10.1002/9780470713990.ch24

Editor Information

  1. 5

    Human Motor Control Section, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, MD, USA

  2. 6

    Department of Neurology, Medical University of Innsbruck, Innsbruck, Austria

Author Information

  1. 1

    Department of Neurology, University of Washington, Seattle, WA, USA

  2. 2

    Department of Neurology, Columbia University Presbyterian Hospital, New York, NY, USA

  3. 3

    Department of Neurology, Columbia University Medical Center, New York, NY, USA

  4. 4

    Takeda General Hospital, Ishida, Fushimi-ku, Kyoto, Japan

Publication History

  1. Published Online: 29 OCT 2008
  2. Published Print: 17 OCT 2008

ISBN Information

Print ISBN: 9780470066485

Online ISBN: 9780470713990

SEARCH

Keywords:

  • myoclonus;
  • etiology;
  • treatment;
  • medication

Summary

This chapter contains sections titled:

  • Clinical Manifestations and Localization of Myoclonus

  • Etiology of Myoclonus

  • Treatment of Myoclonus: General Principles and Commonly used Medications

  • Treatment of Myoclonus: Less Commonly used Medications and Emerging Options

  • Treatment of Myoclonus: Conclusion

  • References